Global Patent Index - EP 0805854 A4

EP 0805854 A4 2000-06-07 - IMMUNOGENIC COMPOSITIONS CONTAINING RECOMBINANT ATTENUATED POXVIRUSES EXPRESSING HTLV ANTIGENS

Title (en)

IMMUNOGENIC COMPOSITIONS CONTAINING RECOMBINANT ATTENUATED POXVIRUSES EXPRESSING HTLV ANTIGENS

Title (de)

IMMUNOGENE ZUSAMMENSETZUNGEN WELCHE REKOMBINANT ABGESCHWÄCHTE POCKENVIREN ENTHALTEN, DIE EIN HTLV ANTIGEN EXPREMIEREN

Title (fr)

COMPOSITIONS IMMUNOGENES CONTENANT DES VIRUS POX ATTENUES EXPRIMANT DES ANTIGENES DE HTLV

Publication

EP 0805854 A4 (EN)

Application

EP 96902688 A

Priority

  • US 9600547 W
  • US 37266495 A

Abstract (en)

[origin: WO9621727A1] Attenuated recombinant viruses containing DNA encoding an HTLV antigen such as HTLVenv or HTLV1171, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses.

IPC 1-7 (main, further and additional classification)

C12N 7/04; A61K 39/12; A61K 39/275; A61K 39/285; A61K 39/295; C12N 15/00; C12N 15/09; C12N 15/63; C12N 15/70; C12N 15/74; C12P 21/04

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); A61K 39/205 (2006.01); A61K 39/21 (2006.01); A61K 39/275 (2006.01); A61K 39/395 (2006.01); A61P 31/12 (2006.01); C07K 14/145 (2006.01); C07K 14/15 (2006.01); C07K 16/08 (2006.01); C12N 7/00 (2006.01); C12N 15/863 (2006.01); C12P 21/02 (2006.01); C12P 21/04 (2006.01); A61K 39/00 (2006.01)

CPC (invention and additional information)

C12N 7/00 (2013.01); A61K 39/12 (2013.01); A61K 39/205 (2013.01); A61K 39/21 (2013.01); C07K 14/005 (2013.01); C12N 15/86 (2013.01); A61K 39/00 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C12N 2710/24043 (2013.01); C12N 2710/24143 (2013.01); C12N 2740/14022 (2013.01); C12N 2740/14034 (2013.01); C12N 2760/20122 (2013.01); C12N 2760/20134 (2013.01)

Citation (search report)

  • No further relevant documents disclosed
  • See also references of WO 9621727A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9621727 A1 19960718; CA 2210294 A1 19960718; CA 2210294 C 20031111; EP 0805854 A1 19971112; EP 0805854 A4 20000607; EP 1840209 A2 20071003; EP 1840209 A3 20080305; JP 2007254489 A 20071004; JP H10512151 A 19981124

INPADOC legal status


2007-04-18 [18W] WITHDRAWN

- Effective date: 20070129

2002-04-03 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20020214

2000-06-07 [A4] SUPPLEMENTARY SEARCH REPORT

- Effective date: 20000420

2000-06-07 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A4

- Designated State(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

1997-11-12 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19970711

1997-11-12 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE